- Markets
- Healthcare
- RAAJMEDI
RAAJMEDI
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
This data is currently unavailable for this company.
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
(In Cr.) |
---|
(In Cr.) | ||||
---|---|---|---|---|
This data is currently unavailable for this company. |
(In %) |
---|
(In Cr.) |
---|
Financial Year (In Cr.) |
---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
Raaj Medisafe India Approves Raising Of Funds
Feb 29 (Reuters) - Raaj Medisafe India Ltd RAAJ.BO:
APPROVED RAISING OF FUNDS THROUGH ISSUANCE OF EQUITY SHARES WORTH 100.1 MILLION RUPEES
Source text for Eikon: ID:nBSE9SjjqW
Further company coverage: RAAJ.BO
(([email protected];))
Feb 29 (Reuters) - Raaj Medisafe India Ltd RAAJ.BO:
APPROVED RAISING OF FUNDS THROUGH ISSUANCE OF EQUITY SHARES WORTH 100.1 MILLION RUPEES
Source text for Eikon: ID:nBSE9SjjqW
Further company coverage: RAAJ.BO
(([email protected];))
Raaj Medisafe India To Consider Raising Of Funds
Feb 23 (Reuters) - Raaj Medisafe India Ltd RAAJ.BO:
TO CONSIDER AND APPROVE RAISING OF FUNDS
Source text for Eikon: ID:nBSE2R3nTW
Further company coverage: RAAJ.BO
(([email protected];))
Feb 23 (Reuters) - Raaj Medisafe India Ltd RAAJ.BO:
TO CONSIDER AND APPROVE RAISING OF FUNDS
Source text for Eikon: ID:nBSE2R3nTW
Further company coverage: RAAJ.BO
(([email protected];))
Raaj Medisafe India Approves Expansion Plan Of Manufacturing Capacities Of Co
Jan 16 (Reuters) - Raaj Medisafe India Ltd RAAJ.BO:
RAAJ MEDISAFE INDIA LTD - APPROVED EXPANSION PLAN OF MANUFACTURING CAPACITIES OF COMPANY
RAAJ MEDISAFE INDIA LTD - REQUIRED INVESTMENT 350-400 MILLION RUPEES
Source text for Eikon: ID:nBSE5VcqhD
Further company coverage: RAAJ.BO
(([email protected];;))
Jan 16 (Reuters) - Raaj Medisafe India Ltd RAAJ.BO:
RAAJ MEDISAFE INDIA LTD - APPROVED EXPANSION PLAN OF MANUFACTURING CAPACITIES OF COMPANY
RAAJ MEDISAFE INDIA LTD - REQUIRED INVESTMENT 350-400 MILLION RUPEES
Source text for Eikon: ID:nBSE5VcqhD
Further company coverage: RAAJ.BO
(([email protected];;))
Events:
More Micro Cap Ideas
See similar 'Micro' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does Raaj Medisafe India do?
Raaj Medisafe India Limited produces, trades, and sells medical disposable products like syringes and needles in India, focusing on efficiency in product service. Currently, the company specializes in manufacturing Disposable Syringes.
Who are the competitors of Raaj Medisafe India?
Raaj Medisafe India major competitors are Hemant Surgical Inds, Kretto Syscon, Centenial Surgical, KMS Medisurgi, Amkay Products, Holmarc Opto-Mech, GKB Ophthalmics. Market Cap of Raaj Medisafe India is ₹91 Crs. While the median market cap of its peers are ₹47 Crs.
Is Raaj Medisafe India financially stable compared to its competitors?
Raaj Medisafe India seems to be less financially stable compared to its competitors. Altman Z score of Raaj Medisafe India is 3.35 and is ranked 6 out of its 8 competitors.
Does Raaj Medisafe India pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Raaj Medisafe India latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has Raaj Medisafe India allocated its funds?
Companies resources are allocated to majorly unproductive assets like Capital Work in Progress
How strong is Raaj Medisafe India balance sheet?
Balance sheet of Raaj Medisafe India is strong. But short term working capital might become an issue for this company.
Is the profitablity of Raaj Medisafe India improving?
Yes, profit is increasing. The profit of Raaj Medisafe India is ₹3.35 Crs for TTM, ₹3.35 Crs for Mar 2024 and ₹3.34 Crs for Mar 2023.
Is the debt of Raaj Medisafe India increasing or decreasing?
Yes, The debt of Raaj Medisafe India is increasing. Latest debt of Raaj Medisafe India is ₹27.96 Crs as of Sep-24. This is greater than Mar-24 when it was ₹25.78 Crs.
Is Raaj Medisafe India stock expensive?
Raaj Medisafe India is expensive when considering the PE ratio, however latest EV/EBIDTA is < 3 yr avg EV/EBIDTA. Latest PE of Raaj Medisafe India is 27.14, while 3 year average PE is 15.75. Also latest EV/EBITDA of Raaj Medisafe India is 15.17 while 3yr average is 16.42.
Has the share price of Raaj Medisafe India grown faster than its competition?
Raaj Medisafe India has given better returns compared to its competitors. Raaj Medisafe India has grown at ~34.9% over the last 1yrs while peers have grown at a median rate of 32.0%
Is the promoter bullish about Raaj Medisafe India?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Raaj Medisafe India is 73.44% and last quarter promoter holding is 73.44%.
Are mutual funds buying/selling Raaj Medisafe India?
There is Insufficient data to gauge this.